↓ Skip to main content

Antidepressants for the negative symptoms of schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 tweeters
weibo
1 weibo user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
133 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Antidepressants for the negative symptoms of schizophrenia
Published in
Cochrane database of systematic reviews, July 2006
DOI 10.1002/14651858.cd005581.pub2
Pubmed ID
Authors

Rummel C, Kissling W, Leucht S, Rummel-Kluge, Christine, Kissling, Werner, Leucht, Stefan

Abstract

Negative symptoms are common in people with schizophrenia and are often difficult to treat with antipsychotic drugs. Treatment often involves the use of various add-on medications such as antidepressants.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 2%
Ireland 1 <1%
Denmark 1 <1%
Australia 1 <1%
Unknown 128 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 22 17%
Student > Ph. D. Student 19 14%
Student > Master 17 13%
Student > Doctoral Student 14 11%
Other 13 10%
Other 30 23%
Unknown 18 14%
Readers by discipline Count As %
Medicine and Dentistry 57 43%
Psychology 23 17%
Nursing and Health Professions 7 5%
Agricultural and Biological Sciences 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 9 7%
Unknown 26 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2017.
All research outputs
#3,101,296
of 12,559,617 outputs
Outputs from Cochrane database of systematic reviews
#5,988
of 10,357 outputs
Outputs of similar age
#48,441
of 212,700 outputs
Outputs of similar age from Cochrane database of systematic reviews
#164
of 240 outputs
Altmetric has tracked 12,559,617 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,357 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,700 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.